TETRALOGIC PHARMACEUTICALS CORP Operating Expenses
TETRALOGIC PHARMACEUTICALS CORP reported Operating Expenses of $9.22 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for the quarter ending 2016-09-30 was $9.22M, a 5.32% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for the quarter ending 2016-06-30 was $5.02M, a 57.02% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for the quarter ending 2016-03-31 was $9.34M, a 12.13% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for the quarter ending 2015-12-31 was $12.94M, a 32.19% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for fiscal 2015 was $44.99M, a 33.17% increase from fiscal 2014.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for fiscal 2014 was $33.79M, a 87.79% increase from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP operating expenses for fiscal 2013 was $17.99M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 126 month |
|---|---|---|---|---|---|
| 2016-09-30 | $9.22M 10-Q · filed 2016-11-03 | $14.24M derived: sum of 2 quarters · filed 2016-11-03 | $23.58M 10-Q · filed 2016-11-03 | $36.53M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | $5.02M 10-Q · filed 2016-08-11 | $14.36M 10-Q · filed 2016-08-11 | $27.30M derived: sum of 3 quarters · filed 2016-08-11 | $37.04M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-03-31 | $9.34M 10-Q · filed 2016-05-04 | $22.28M derived: sum of 2 quarters · filed 2016-05-04 | $32.03M derived: sum of 3 quarters · filed 2016-11-03 | $43.70M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-12-31 | $12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $22.69M derived: sum of 2 quarters · filed 2016-11-03 | $34.36M derived: sum of 3 quarters · filed 2016-11-03 | $44.99M 10-K · filed 2016-03-16 | |
| 2015-09-30 | $9.74M 10-Q · filed 2016-11-03 | $21.42M derived: sum of 2 quarters · filed 2016-11-03 | $32.05M 10-Q · filed 2016-11-03 | $41.84M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | $11.67M 10-Q · filed 2016-08-11 | $22.30M 10-Q · filed 2016-08-11 | $32.10M derived: sum of 3 quarters · filed 2016-08-11 | $41.67M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $10.63M 10-Q · filed 2016-05-04 | $20.42M derived: sum of 2 quarters · filed 2016-05-04 | $30.00M derived: sum of 3 quarters · filed 2016-05-04 | $38.78M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $19.37M derived: sum of 2 quarters · filed 2016-03-16 | $28.15M derived: sum of 3 quarters · filed 2016-03-16 | $33.79M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $9.58M 10-Q · filed 2015-11-04 | $18.36M derived: sum of 2 quarters · filed 2015-11-04 | $23.99M 10-Q · filed 2015-11-04 | $31.40M derived: sum of 4 quarters · filed 2015-11-04 | |
| 2014-06-30 | $8.79M 10-Q · filed 2015-08-05 | $14.42M 10-Q · filed 2015-08-05 | $21.82M derived: sum of 3 quarters · filed 2015-08-05 | $26.14M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $5.63M 10-Q · filed 2015-05-14 | $13.04M derived: sum of 2 quarters · filed 2015-05-14 | $17.36M derived: sum of 3 quarters · filed 2015-05-14 | $20.40M derived: sum of 4 quarters · filed 2015-05-14 | $107.86M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $11.73M derived: sum of 2 quarters · filed 2015-02-26 | $14.77M derived: sum of 3 quarters · filed 2015-02-26 | $17.99M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $4.32M 10-Q · filed 2014-11-05 | $7.36M derived: sum of 2 quarters · filed 2014-11-05 | $10.59M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $3.04M 10-Q · filed 2014-08-05 | $6.26M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | $3.22M 10-Q · filed 2014-05-08 |